Name: Staphylococcus epidermidis DSM 1798
Creator: BacDive
License: https://creativecommons.org/licenses/by/4.0/

Strain identifier

BacDive ID: 14522

Type strain:

Species: Staphylococcus epidermidis

Culture col. no.: DSM 1798, ATCC 12228, WDCM 00036, CCUG 21989, PCI 1200, JCM 20345, IAM 12012, IFO 12993, NBRC 12993, NCIMB 8853, CIP 68.21, LMG 10273, CCM 4418, CECT 231, NCTC 13360, WHO 12

Strain history: CIP <- 1968, Y.A. Chabbert, Inst. Pasteur, Paris, France: strain WHO 12 <- FDA, Washington, USA: strain PCI 1200, Micrococcus pyogenes var. albus

NCBI tax ID(s): 176280 (strain), 1282 (species)

SI-ID 13849

LMG 10273, ATCC 12228, IFO 12993, NCIMB 8853, NCIB 8853, CCUG 21989, IAM 12012, CCM 4418, CIP 68.21, CECT 231, ATCC 1798, CCRC 11030, KCTC 1917, NBRC 12993, BCRC 11030, CBMAI 604, NCAIM B.01875, NCAIM B.02055, NCIM 2493, CDBB 1012, ACM 2063, NRRL B-4268, NRRL B-4377, CNCTC 5212, CGMCC 1.2429, JCM 20345, DSM 1798

Other strains from Staphylococcus epidermidis

Section

Staphylococcus epidermidis DSM 1798 is a facultative anaerobe, Gram-positive human pathogen that was isolated from unknown source of isolation.

Gram-positive
facultative anaerobe
human pathogen
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Bacillota*
	Class	*Bacilli*
	Order	*Caryophanales*
	Family	*Staphylococcaceae*
	Genus	*Staphylococcus*
	Species	**Staphylococcus epidermidis**
	Full Scientific Name (LPSN)	Staphylococcus epidermidis (Winslow and Winslow 1908) Evans 1916 (Approved Lists 1980)

Synonym

"Albococcus epidermidis"

Information on morphological and physiological properties Morphology

[Ref.: #119105]	Gram stain	positive
[Ref.: #69480]	Gram stain	positive Confidence in %93.041

[Ref.: #119105]	Cell shape	coccus-shaped

[Ref.: #119105]	Motility	no
[Ref.: #69480]	Motility	no Confidence in %91.189

[Ref.: #659]	Type of hemolysis	beta
[Ref.: #659]	Hemolysis ability	1
[Ref.: #659]	Incubation period	1-2 days

Information on culture and growth conditions Culture and growth conditions

[Ref.: #659]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #659]

Culture medium growth

[Ref.: #659]

Culture medium link

Medium recipe at MediaDive

[Ref.: #659]

Culture medium composition

expand / minimize

[Ref.: #659]

Culture medium

TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)

[Ref.: #659]

Culture medium growth

[Ref.: #659]

Culture medium link

Medium recipe at MediaDive

[Ref.: #659]

Culture medium composition

expand / minimize

[Ref.: #41765]

Culture medium

MEDIUM 72- for trypto casein soja agar

[Ref.: #41765]

Culture medium growth

[Ref.: #41765]

Culture medium composition

expand / minimize

[Ref.: #119105]

Culture medium

CIP Medium 72

[Ref.: #119105]

Culture medium growth

[Ref.: #119105]

Culture medium link

Medium recipe provided by DSMZ

[Ref.: #119105]

Culture medium

CIP Medium 29

[Ref.: #119105]

Culture medium growth

[Ref.: #119105]

Culture medium link

Medium recipe provided by DSMZ

[Ref.: #119105]

Culture medium

CIP Medium 3

[Ref.: #119105]

Culture medium growth

[Ref.: #119105]

Culture medium link

Medium recipe provided by DSMZ

	Kind of temperature		Temperature
[Ref.: #659]		growth	37 °C
[Ref.: #41765]		growth	37 °C
[Ref.: #67770]		growth	37 °C
[Ref.: #119105]		growth	22-41 °C
[Ref.: #119105]	no	growth	15 °C

Information on physiology and metabolism Physiology and metabolism

[Ref.: #119105]

Oxygen tolerance

facultative anaerobe

Note that the displayed test results represent raw data and therefore may deviate!

Antibiotic susceptibility testing

Test 1

Test 2

Test 3

Test 4

Test 5

Test 6

Test 7

Test 8

Test 9

Reference

[Ref.: #659]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
20
34-36
22
28
24
36
36
32
resistant0
50
8
32-34
30-32
28-30
22
34-36
34-36
30-32
32
10
18-20
30
18
12
40
24-26
12-14
30-32
38-40
40
32-34
34-36
resistant0
34
20
26

[Ref.: #659]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
22-24
36
26
30
24-26
38
38
36
resistant0
>50
10
36
30
30
22
38
38
32
34
8
20
32
20
12-14
32
26
16-18
32
40-42
42-44
38
40
resistant0
34-36
20
28-30

[Ref.: #659]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
24
38
28
30
26
40
38-40
34
resistant0
>50
10
40
32
30
22
38
40
32-34
36
10
20
32
16-18
14
32
30
20
32
42
44
38
42-44
resistant0
36
20
30

[Ref.: #659]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
22-24
36-38
24
30
24
38-40
38
32-34
resistant0
>50
10
34-36
28
30
22
34-36
36-38
32
32-34
10
20
32
20
12-14
30
26
14-16
32-34
42
44
36
34-36
resistant0
34
20
26

[Ref.: #659]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
24
36-38
26
30-32
26
38
38
34-36
resistant0
>50
10
38-40
30
32
22-24
36-38
38
32
36
12
20
34
20
14
32
28
18
34
44
46
38
36
resistant0
34-36
20
28-30

[Ref.: #659]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
30
38
32
36-38
30
42
40
38
resistant0
>50
10
36
34
34-36
24
40
42
36
38
12
22
34
22
16
36
30
16
38
42-44
42-44
40
42-44
resistant0
36
22
32

[Ref.: #659]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
22
36
24-26
32
26
40
40
34-36
resistant0
>50
10
36-38
32
32
22-24
36
38-40
32
32
12
18-20
30-32
16-18
14-16
32
28
18
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #659]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
26
36-38
28
34
28
40-42
40
36
resistant0
>50
10
36-38
34
30
24
40-42
42
34
38-40
10
20
34
20-22
16
32
30
18
36
46-48
48
38
40-42
resistant0
36-38
20
30

[Ref.: #659]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
26
36-38
28
34
28
40-42
40
36
resistant0
>50
10
36-38
34
30
24
40-42
42
34
38-40
10
20
34
20-22
16
32
30
18
36
46-48
48
38
40-42
resistant0
36-38
20
30

Only first 15 entries are displayed. Click here to see all.

[Ref.: #69480]

Ability of spore formation

no Confidence in %92.724

[Ref.: #67770]

Observation

Assay of Antibiotics (Japanese Pharmacopoeia, 14 ed.)

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68375]	arabinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	arginine ChEBI	+	hydrolysis	* from API ID32STA
[Ref.: #68378]	arginine ChEBI	-	hydrolysis	* from API STA
[Ref.: #68375]	cellobiose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68378]	D-fructose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	D-fructose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68379]	D-glucose ChEBI	+	fermentation	* from API Coryne, API ID32STA
[Ref.: #68378]	D-glucose ChEBI	-	builds acid from	* from API STA
[Ref.: #68378]	D-mannitol ChEBI	-	builds acid from	* from API STA
[Ref.: #68379]	D-mannitol ChEBI	-	fermentation	* from API Coryne, API ID32STA
[Ref.: #68378]	D-mannose ChEBI	+	builds acid from	* from API STA
[Ref.: #68379]	D-ribose ChEBI	-	fermentation	* from API Coryne, API ID32STA
[Ref.: #68378]	D-xylose ChEBI	-	builds acid from	* from API STA
[Ref.: #68379]	D-xylose ChEBI	-	fermentation	* from API Coryne
[Ref.: #68379]	esculin ChEBI	-	hydrolysis	* from API Coryne, API ID32STA
[Ref.: #68379]	gelatin ChEBI	+	hydrolysis	* from API Coryne
[Ref.: #68379]	glycogen ChEBI	-	fermentation	* from API Coryne
[Ref.: #119105]	hippurate ChEBI	-	hydrolysis
[Ref.: #68378]	lactose ChEBI	+	builds acid from	* from API STA
[Ref.: #68379]	lactose ChEBI	+	fermentation	* from API Coryne, API ID32STA
[Ref.: #68378]	maltose ChEBI	+	builds acid from	* from API STA
[Ref.: #68379]	maltose ChEBI	+	fermentation	* from API Coryne, API ID32STA
[Ref.: #68378]	melibiose ChEBI	-	builds acid from	* from API STA
[Ref.: #68378]	methyl alpha-D-glucopyranoside ChEBI	+	builds acid from	* from API STA
[Ref.: #68378]	N-acetylglucosamine ChEBI	-	builds acid from	* from API STA
[Ref.: #119105]	nitrate ChEBI	+	reduction
[Ref.: #119105]	nitrate ChEBI	+	respiration
[Ref.: #68379]	nitrate ChEBI	+	reduction	* from API Coryne, API ID32STA
[Ref.: #68378]	nitrate ChEBI	-	reduction	* from API STA
[Ref.: #119105]	nitrite ChEBI	-	reduction
[Ref.: #68375]	ornithine ChEBI	-	degradation	* from API ID32STA
[Ref.: #68378]	raffinose ChEBI	-	builds acid from	* from API STA
[Ref.: #68375]	raffinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68379]	sucrose ChEBI	+	fermentation	* from API Coryne, API ID32STA
[Ref.: #68378]	sucrose ChEBI	-	builds acid from	* from API STA
[Ref.: #68378]	trehalose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	trehalose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68379]	urea ChEBI	+	hydrolysis	* from API Coryne, API ID32STA, API STA
[Ref.: #68378]	xylitol ChEBI	-	builds acid from	* from API STA
	Only first 10 entries are displayed. Click here to see all.

	Antibiotica	Metabolite	Antibiotic resistance
[Ref.: #68378]		lysostaphin	yes	* from API STA

	Metabolite production	Metabolite	Production
[Ref.: #119105]		indole ChEBI	no
[Ref.: #68378]		acetoin ChEBI	yes	* from API STA

	Physiological tests	Metabolite	Voges-Proskauer-test
[Ref.: #119105]		acetoin ChEBI	-
[Ref.: #68378]		acetoin ChEBI	+	* from API STA

	Enzyme	Enzyme activity	EC number
[Ref.: #68382]	acid phosphatase	+	3.1.3.2	* from API zym
[Ref.: #119105]	alcohol dehydrogenase	+	1.1.1.1
[Ref.: #68378]	alkaline phosphatase	+	3.1.3.1	* from API STA, API ID32STA, API Coryne, API zym
[Ref.: #68382]	alpha-chymotrypsin	-	3.4.21.1	* from API zym
[Ref.: #68382]	alpha-fucosidase	-	3.2.1.51	* from API zym
[Ref.: #68382]	alpha-galactosidase	-	3.2.1.22	* from API zym
[Ref.: #68382]	alpha-glucosidase	+	3.2.1.20	* from API zym
[Ref.: #68379]	alpha-glucosidase	-	3.2.1.20	* from API Coryne
[Ref.: #68382]	alpha-mannosidase	-	3.2.1.24	* from API zym
[Ref.: #68375]	arginine dihydrolase	+	3.5.3.6	* from API ID32STA
[Ref.: #68378]	arginine dihydrolase	-	3.5.3.6	* from API STA
[Ref.: #119105]	beta-galactosidase	+	3.2.1.23
[Ref.: #68379]	beta-galactosidase	+	3.2.1.23	* from API Coryne
[Ref.: #68382]	beta-galactosidase	-	3.2.1.23	* from API zym
[Ref.: #68375]	beta-glucosidase	-	3.2.1.21	* from API ID32STA, API Coryne, API zym
[Ref.: #68375]	beta-glucuronidase	-	3.2.1.31	* from API ID32STA, API Coryne, API zym
[Ref.: #119105]	caseinase	+	3.4.21.50
[Ref.: #659]	catalase	+	1.11.1.6
[Ref.: #119105]	catalase	+	1.11.1.6
[Ref.: #68379]	catalase	+	1.11.1.6	* from API Coryne
[Ref.: #119105]	coagulase	-
[Ref.: #68382]	cystine arylamidase	-	3.4.11.3	* from API zym
[Ref.: #659]	cytochrome-c oxidase	-	1.9.3.1
[Ref.: #119105]	DNase	-
[Ref.: #68382]	esterase (C 4)	+		* from API zym
[Ref.: #68382]	esterase lipase (C 8)	+		* from API zym
[Ref.: #119105]	gelatinase	+/-
[Ref.: #68379]	gelatinase	+		* from API Coryne
[Ref.: #68375]	L-arginine arylamidase	-		* from API ID32STA
[Ref.: #119105]	lecithinase	+
[Ref.: #68382]	leucine arylamidase	-	3.4.11.1	* from API zym
[Ref.: #68382]	lipase (C 14)	-		* from API zym
[Ref.: #119105]	lysine decarboxylase	-	4.1.1.18
[Ref.: #68379]	N-acetyl-beta-glucosaminidase	-	3.2.1.52	* from API Coryne, API zym
[Ref.: #68382]	naphthol-AS-BI-phosphohydrolase	-		* from API zym
[Ref.: #119105]	ornithine decarboxylase	-	4.1.1.17
[Ref.: #68375]	ornithine decarboxylase	-	4.1.1.17	* from API ID32STA
[Ref.: #119105]	oxidase	-
[Ref.: #119105]	phenylalanine ammonia-lyase	-	4.3.1.24
[Ref.: #68379]	pyrazinamidase	+	3.5.1.B15	* from API Coryne
[Ref.: #68375]	pyrrolidonyl arylamidase	-	3.4.19.3	* from API ID32STA, API Coryne
[Ref.: #68382]	trypsin	-	3.4.21.4	* from API zym
[Ref.: #119105]	urease	+	3.5.1.5
[Ref.: #68378]	urease	+	3.5.1.5	* from API STA, API ID32STA, API Coryne
[Ref.: #68382]	valine arylamidase	-		* from API zym
	Only first 10 entries are displayed. Click here to see all.

Fatty acid profile

Metadata FA analysis

Reference

[Ref.: #47537]

Fatty acid	Percentage	ECL
C15:0 ANTEISO	53.4	14.711
C17:0 anteiso	11.6	16.722
C15:0 ISO	9	14.621
C17:0 iso	4.9	16.629
C14:0 ISO	3.4	13.618
C18:2 ω6,9c/C18:0 ANTE	3.3	17.724
C18:0	3.2	18
C19:0 ANTEISO	2.6	18.729
C16:0 iso	2.5	15.626
C19:0 ISO	1.7	18.633
C16:0	1.6	16
C18:0 ISO	1.3	17.632
C20:0	1	20
C20:2 ω6,9c	0.6	19.735

API® Biotype100:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
[Ref.: #119105]	3244	not determinedn.d.	+	+	+	-	+	-	-	+	-	+	+	+	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

API® Coryne:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Reduction of nitrateNIT	PyrazinamidasePYZ	Pyrrolidonyl arylamidasePYRA	Alkaline phosphatasePAL	beta-Glucuronidasebeta GUR	beta-Galactosidasebeta GAL	alpha-Glucosidasealpha GLU	N-Acetyl-beta-Glucosidasebeta NAG	Esculin hydrolysis/beta-GlucosidaseESC	Urease/urea hydrolysisURE	Gelatinase/gelatin hydrolysisGEL	Control fermentationControl	Fermentation of D-glucoseGLU	Fermentation of D-riboseRIB	Fermentation of D-xyloseXYL	Fermentation of D-mannitolMAN	Fermentation of maltoseMAL	Fermentation of lactoseLAC	Fermentation of sucroseSAC	Fermentation of glycogenGLYG	CatalaseCAT
[Ref.: #47537]	2937	+	+	-	+	-	+	-	-	-	+	+	-	+	-	-	-	+	+	+	-	+

API® ID32STA:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	Ornithine decarboxylaseODC	Esculin hydrolysisESC	Fermentation of D-glucoseGLU	Fermentation of D-fructoseFRU	Fermentation of D-mannoseMNE	Fermentation of maltoseMAL	Fermentation of lactoseLAC	Fermentation of trehaloseTRE	Fermentation of D-mannitolMAN	Fermentation of raffinoseRAF	Fermentation of D-riboseRIB	Fermentation of cellobioseCEL	Reduction of nitrateNIT	Acetoin production (Voges Proskauer test)VP	beta-Galactosidasebeta GAL	L-arginine arylamidaseArgA	Alkaline phosphatasePAL	Pyrrolidonyl arylamidasePyrA	Novobiocin resistanceNOVO	Fermentation of sucroseSAC	Fermentation of N-acetyl-glucosamineNAG	Fermentation of turanoseTUR	Fermentation of arabinoseARA	beta-Glucuronidasebeta GUR
[Ref.: #659]	6305	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	-	+/-	-	+	-	-	+	-	+/-	-	-
[Ref.: #659]	5785	+	+	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+	-	-	+	-	+/-	-	-
[Ref.: #659]	5786	+	+	-	-	+	+	-	+	+	-	-	-	-	-	+	-	-	-	+	-	-	+	-	+	-	-
[Ref.: #659]	5787	+	+	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+	-	-	+	-	+/-	-	-
[Ref.: #659]	5788	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	-	-	-	+	-	+	+	+/-	+	-	-
[Ref.: #659]	5789	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	+	-	-	+	-	+	+	-	+	-	-
[Ref.: #659]	5790	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	-	+	-	+	-	-	+	-	-	-	-
[Ref.: #47537]	1938	+	+	-	-	+	+	-	+	+	-	-	-	-	-	+	-	-	-	+	-	-	+	-	-	-	-
[Ref.: #659]	6182	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	-	-	-	+	-	-	+	-	+	-	-
[Ref.: #659]	6216	+	+	-	-	+	+	-	+	+	-	-	-	-	-	+	+	+	-	+	-	-	+	-	-	-	-
[Ref.: #659]	6258	+	+	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+	-	-	+	-	+	-	-
[Ref.: #659]	6361	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	+	-	-	+	-	-	+	-	-	-	-

API® STA:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	Acid from D-glucoseGLU	Acid from D-fructoseFRU	Acid from D-mannoseMNE	Acid from maltoseMAL	Acid from lactoseLAC	Acid from trehaloseTRE	Acid from D-mannitolMAN	Acid from xylitolXLT	Acid from melibioseMEL	Reduction of nitrateNIT	Alkaline phosphatasePAL	Acetoin production (Voges Proskauer test)VP	Acid from raffinoseRAF	Acid from D-xyloseXYL	Acid from sucroseSAC	Acid from methyl-alpha-D-glucopyranosideMDG	Acid from N-acetyl-glucosamineNAG	Arginine dihydrolaseADH	Urease/urea hydrolysisURE	Resistance to lysostaphin (EC 3.4.24.75)LSTR
[Ref.: #47537]	12	not determinedn.d.	-	+	+	+	+	+	-	-	-	-	+	+	-	-	-	+	-	-	+	+

API® zym:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	2-naphthyl phosphateAlkaline phosphatase	2-naphthyl butyrateEsterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	2-naphthyl myristateLipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	N-benzoyl-DL-arginine-2-naphthylamideTrypsin	N-glutaryl-phenylalanine-2-naphthylamidealpha- Chymotrypsin	2-naphthyl phosphateAcid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	6-Br-2-naphthyl-alphaD-galactpyranosidealpha- Galactosidase	2-naphthyl-betaD-galactpyranosidebeta- Galactosidase	Naphthol-AS-BI-betaD-glucuronidebeta- Glucuronidase	2-naphthyl-alphaD-glucopyranosidealpha- Glucosidase	6-Br-2-naphthyl-betaD-glucopyranosidebeta- Glucosidase	1-naphthyl-N-acetyl-betaD-glucosaminideN-acetyl-beta- glucosaminidase	6-Br-2-naphthyl-alphaD-mannopyranosidealpha- Mannosidase	2-naphthyl-alphaL-fucopyranosidealpha- Fucosidase
[Ref.: #47537]	4577	-	+	+	+	-	-	-	-	-	-	+	-	-	-	-	+	-	-	-	-
[Ref.: #119105]	13139	-	+	+	+	-	-	-	-	-	-	+	-	-	-	-	+	-	-	-	-

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #659]	Sample type/isolated from	unknown source of isolation
* marker position based on {}

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #659]	Pathogenicity (human)	yes
[Ref.: #659]	Pathogenicity (animal)	yes
[Ref.: #659]	Biosafety level	2	Risk group (German classification) According to TRBA 466
[Ref.: #119105]	Biosafety level	1	Risk group (French classification)

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #124043]	Staphylococcus epidermidis JCM 20345 gene for 16S rRNA, partial sequence.	LC654888	1473	GenBank ENA	1282 tax ID	*
[Ref.: #124043]	Staphylococcus epidermidis gene for 16S rRNA, partial sequence, strain: NBRC 12993.	AB680360	1476	GenBank ENA	1282 tax ID	*
[Ref.: #20218]	Staphylococcus epidermidis 16S-23S ribosomal RNA spacer region	U90018	261	GenBank ENA	1282 tax ID	*
[Ref.: #20218]	Staphylococcus epidermidis 16S-23S ribosomal RNA spacer region	U90019	263	GenBank ENA	1282 tax ID	*
[Ref.: #20218]	Staphylococcus epidermidis 16S-23S ribosomal RNA spacer region	U90020	263	GenBank ENA	1282 tax ID	*
[Ref.: #20218]	Staphylococcus epidermidis 16S-23S ribosomal RNA spacer region	U90021	262	GenBank ENA	1282 tax ID	*
[Ref.: #20218]	Staphylococcus epidermidis 16S-23S ribosomal RNA spacer region	U39771	261	GenBank ENA	1282 tax ID	*
[Ref.: #20218]	Staphylococcus epidermidis strain DSM 1798 16S ribosomal RNA gene, partial sequence	AY688052	464	GenBank ENA	1282 tax ID	*

Genome sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Staphylococcus epidermidis ATCC 12228	GCA_001999745	contig	GenBank ENA	1282 tax ID
[Ref.: #67770]	Staphylococcus epidermidis ATCC 12228	GCA_008868245	contig	GenBank ENA	176280 tax ID
[Ref.: #66792]	Staphylococcus epidermidis ATCC 12228 DE0527	GCA_007666585	scaffold	GenBank ENA	176280 tax ID	*
[Ref.: #66792]	Staphylococcus epidermidis ATCC 12228	176280.70	plasmid	PATRIC	176280 tax ID	*
[Ref.: #66792]	Staphylococcus epidermidis ATCC 12228	176280.10	complete	PATRIC	176280 tax ID	*
[Ref.: #66792]	Staphylococcus epidermidis ATCC 12228	176280.71	plasmid	PATRIC	176280 tax ID	*

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Staphylococcus epidermidis ATCC 12228 ATCC 12228 NCBI: GCA_000007645.1
[Ref.: #69481]	spore-forming	no	68	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Staphylococcus epidermidis ATCC 12228 ATCC 12228 NCBI: GCA_000007645.1
[Ref.: #69480]	motile	no	91.189	no
[Ref.: #69480]	flagellated	no	92.776	no
[Ref.: #69480]	gram-positive	yes	93.041	no
[Ref.: #69480]	anaerobic	no	98.979	no
[Ref.: #69480]	halophile	yes	95.665	no
[Ref.: #69480]	spore-forming	no	92.724	no
[Ref.: #69480]	thermophile	no	99.87	no
[Ref.: #69480]	glucose-util	yes	91.415	no
[Ref.: #69480]	aerobic	yes	85.591	no
[Ref.: #69480]	glucose-ferment	yes	79.374	yes

Availability in culture collections External links

[Ref.: #659]

Culture collection no.

DSM 1798, ATCC 12228, WDCM 00036, CCUG 21989, PCI 1200, JCM 20345, IAM 12012, IFO 12993, NBRC 12993, NCIMB 8853, CIP 68.21, LMG 10273, CCM 4418, CECT 231, NCTC 13360, WHO 12

[Ref.: #83653]

SI-ID 13849

Literature:

Only first 10 entries are displayed. Click here to see all.

	Title	Authors	Journal	DOI	Year
Pathogenicity	Synthesis, Characterization, Biological Evaluation and DNA Interaction Studies of 4-Aminophenol Derivatives: Theoretical and Experimental Approach.	Rafique B, Kalsoom S, Sajini AA, Ismail H, Iqbal M	Molecules	10.3390/molecules27041352	2022	*
Pathogenicity	De-novo fabrication of sunlight irradiated silver nanoparticles and their efficacy against E. coli and S. epidermidis.	Arshad H, Sadaf S, Hassan U	Sci Rep	10.1038/s41598-021-04674-x	2022	*
Metabolism	The Extracellular Vesicles from the Commensal Staphylococcus Epidermidis ATCC12228 Strain Regulate Skin Inflammation in the Imiquimod-Induced Psoriasis Murine Model.	Gomez-Chavez F, Cedillo-Pelaez C, Zapi-Colin LA, Gutierrez-Gonzalez G, Martinez-Torres I, Peralta H, Chavez-Galan L, Avila-Calderon ED, Contreras-Rodriguez A, Bartolo-Aguilar Y, Rodriguez-Martinez S, Cancino-Diaz ME, Cancino-Diaz JC	Int J Mol Sci	10.3390/ijms222313029	2021	*
Pathogenicity	The biofilm inhibition activity of a NO donor nanosilica with enhanced antibiotics action.	da Silva Filho PM, Andrade AL, Lopes JBAC, Pinheiro AA, de Vasconcelos MA, Fonseca SGDC, Lopes LGF, Sousa EHS, Teixeira EH, Longhinotti E	Int J Pharm	10.1016/j.ijpharm.2021.121220	2021	*
Pathogenicity	[In vivo study on the effects of intercellular adhesion operon of Staphylococcus epidermidis on the inflammation associated with bacteria-fungal mixed biofilm].	Zhang G, Wan Z, Wang X, Huang Y, Zhou Y, Chen Y, Lei Y, Qiao L	Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi	10.7507/1002-1892.202104061	2021	*
Metabolism	Electricity-producing Staphylococcus epidermidis counteracts Cutibacterium acnes.	Marito S, Keshari S, Traisaeng S, My DTT, Balasubramaniam A, Adi P, Hsieh MF, Herr DR, Huang CM	Sci Rep	10.1038/s41598-021-91398-7	2021	*
Pathogenicity	PHMB-loaded PDMS and its antimicrobial properties for biomedical applications.	Montemezzo M, Ferrari MD, Kerstner E, Santos VD, Victorazzi Lain V, Wollheim C, Frozza CODS, Roesch-Ely M, Baldo G, Brandalise RN	J Biomater Appl	10.1177/08853282211011921	2021	*
Metabolism	Salvadora persica mediated synthesis of silver nanoparticles and their antimicrobial efficacy.	Arshad H, Sami MA, Sadaf S, Hassan U	Sci Rep	10.1038/s41598-021-85584-w	2021	*
Metabolism	Comprehensive Succinylome Profiling Reveals the Pivotal Role of Lysine Succinylation in Energy Metabolism and Quorum Sensing of Staphylococcus epidermidis.	Zhao Y, Han Y, Sun Y, Wei Z, Chen J, Niu X, An Q, Zhang L, Qi R, Gao X	Front Microbiol	10.3389/fmicb.2020.632367	2021	*
Metabolism	Repurposing INCI-registered compounds as skin prebiotics for probiotic Staphylococcus epidermidis against UV-B.	Balasubramaniam A, Adi P, Tra My DT, Keshari S, Sankar R, Chen CL, Huang CM	Sci Rep	10.1038/s41598-020-78132-5	2020	*
Pathogenicity	Enhancing Drug Efficacy against Mastitis Pathogens-An In Vitro Pilot Study in Staphylococcus aureus and Staphylococcus epidermidis.	Rajamanickam K, Yang J, Chidambaram SB, Sakharkar MK	Animals (Basel)	10.3390/ani10112117	2020	*
Pathogenicity	Susceptibility of Mature Staphylococcus Biofilms to Chinese Herbal Decoction Sanhuang Jiedu: An In Vitro Study.	Zhang S, Wang X, Shi X, Tan H	Biomed Res Int	10.1155/2020/7473942	2020	*
Pathogenicity	Design, synthesis and activity against Staphylococcus epidermidis of 5-chloro-2- or 5-chloro-4-methyl-9H-xanthen-9-one and some of its derivatives.	Mazur G, Skiba-Kurek I, Karczewska E, Panczyk-Straszak K, Jaworska J, Waszkielewicz AM	Chem Biol Drug Des	10.1111/cbdd.13803	2020	*
Metabolism	Phenylpiperazine 5,5-Dimethylhydantoin Derivatives as First Synthetic Inhibitors of Msr(A) Efflux Pump in Staphylococcus epidermidis.	Witek K, Latacz G, Kaczor A, Czekajewska J, Zeslawska E, Chudzik A, Karczewska E, Nitek W, Kiec-Kononowicz K, Handzlik J	Molecules	10.3390/molecules25173788	2020	*
Metabolism	A eukaryotic expression strategy for producing the novel antimicrobial peptide PRW4.	Zhan N, Wang T, Zhang L, Shan A	Braz J Microbiol	10.1007/s42770-020-00291-4	2020	*
Metabolism	Synthesis, Molecular Docking Studies and Antibacterial Activities of Novel Monocationic Indole-benzimidazole Derivatives.	Ates-Alagoz Z, Kisla MM, Goker H, Yildiz S	Med Chem	10.2174/1573406416666200420080459	2021	*
Pathogenicity	Imaging studies of bacterial biofilms on cochlear implants-Bioactive glass (BAG) inhibits mature biofilm.	Kirchhoff L, Arweiler-Harbeck D, Arnolds J, Hussain T, Hansen S, Bertram R, Buer J, Lang S, Steinmann J, Hoing B	PLoS One	10.1371/journal.pone.0229198	2020	*
Pathogenicity	Antibacterial sesquiterpenes from the stems and roots of Thuja sutchuenensis.	Wang M, Zhao L, Chen K, Shang Y, Wu J, Guo X, Chen Y, Liu H, Tan H, Qiu SX	Bioorg Chem	10.1016/j.bioorg.2020.103645	2020	*
Pathogenicity	Resistance and cross-resistance in Staphylococcus spp. strains following prolonged exposure to different antiseptics.	Nicolae Dopcea G, Dopcea I, Nanu AE, Diguta CF, Matei F	J Glob Antimicrob Resist	10.1016/j.jgar.2019.10.021	2019	*
Pathogenicity	Synthesis and Antibacterial Evaluation of Mannich Bases Derived from 1,2,4-Triazole.	Paneth A, Trotsko N, Popiolek L, Grzegorczyk A, Krzanowski T, Janowska S, Malm A, Wujec M	Chem Biodivers	10.1002/cbdv.201900377	2019	*
Pathogenicity	An underestimated pathogen: Staphylococcus epidermidis induces pro-inflammatory responses in human alveolar epithelial cells.	Dong Y, Glaser K, Schlegel N, Claus H, Speer CP	Cytokine	10.1016/j.cyto.2019.154761	2019	*
Pathogenicity	2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent staphylococcal biofilm inhibitors.	Cascioferro S, Parrino B, Petri GL, Cusimano MG, Schillaci D, Di Sarno V, Musella S, Giovannetti E, Cirrincione G, Diana P	Eur J Med Chem	10.1016/j.ejmech.2019.02.007	2019	*
Metabolism	Differential involvement of glycans in the binding of Staphylococcus epidermidis and Corynebacterium spp. to human sweat.	Lin CH, Peterson RA, Gueniche A, de Beaumais SA, Hourblin V, Breton L, Dalko M, Packer NH	Microbiol Res	10.1016/j.micres.2018.12.007	2018	*
Pathogenicity	Molecular characterization of methicillin-resistant Staphylococcus aureus isolates from rural community settings in Trinidad and Tobago.	Vire FP, Akpaka PE, Unakal C	Niger J Clin Pract	10.4103/njcp.njcp_269_18	2018	*
Enzymology	Phytochemical analysis and antimicrobial activity of aqueous and methanolic extracts of the flowers of Nelumbium speciosum.	Bashir S, Sial RN, Ashraf MU, Mushtaq MN, Adnan MA, Erum A	Pak J Pharm Sci		2018	*
Pathogenicity	N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.	Asadipour A, Moshafi MH, Khosravani L, Moghimi S, Amou E, Firoozpour L, Ilbeigi G, Beiki K, Soleimani E, Foroumadi A	Daru	10.1007/s40199-018-0226-0	2018	*
Pathogenicity	In vitro bactericidal activity of 0.6% povidone-iodine eye drops formulation.	Musumeci R, Bandello F, Martinelli M, Calaresu E, Cocuzza CE	Eur J Ophthalmol	10.1177/1120672118802541	2018	*
Genetics	[Comparison of genotypic and phenotypic characteristics in biofilm production of Staphylococcus aureus isolates].	Sahin R, Kaleli I	Mikrobiyol Bul	10.5578/mb.66773	2018	*
Pathogenicity	Lipid transfer protein isolated from noni seeds displays antibacterial activity in vitro and improves survival in lethal sepsis induced by CLP in mice.	Souza AA, Costa AS, Campos DCO, Batista AHM, Sales GWP, Nogueira NAP, Alves KMM, Coelho-de-Souza AN, Oliveira HD	Biochimie	10.1016/j.biochi.2018.03.011	2018	*
Biotechnology	The narrowing down of inoculated communities of coagulase-negative staphylococci in fermented meat models is modulated by temperature and pH.	Stavropoulou DA, Van Reckem E, De Smet S, De Vuyst L, Leroy F	Int J Food Microbiol	10.1016/j.ijfoodmicro.2018.03.008	2018	*
Pathogenicity	In vitro evaluation of new 2-phenoxy-benzo[g][1,2,4]triazolo[1,5-a]quinazoline derivatives as antimicrobial agents.	Abuelizz HA, El-Dib RA, Marzouk M, Al-Salahi R	Microb Pathog	10.1016/j.micpath.2018.02.018	2018	*
Metabolism	Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen.	Costa SS, Viveiros M, Pomba C, Couto I	J Antimicrob Chemother	10.1093/jac/dkx400	2018	*
Genetics	Complete Genome Sequence of Staphylococcus epidermidis ATCC 12228 Chromosome and Plasmids, Generated by Long-Read Sequencing.	MacLea KS, Trachtenberg AM	Genome Announc	10.1128/genomeA.00954-17	2017	*
Pathogenicity	Lipophilic gold(I) complexes with 1,3,4-oxadiazol-2-thione or 1,3-thiazolidine-2-thione moieties: synthesis and their cytotoxic and antimicrobial activities.	de Almeida AM, de Oliveira BA, de Castro PP, de Mendonca CC, Furtado RA, Nicolella HD, da Silva VL, Diniz CG, Tavares DC, Silva H, de Almeida MV	Biometals	10.1007/s10534-017-0046-6	2017	*
Pathogenicity	Inhibition of bacterial biofilms by carboxymethyl chitosan combined with silver, zinc and copper salts.	Goncalves RC, da Silva DP, Signini R, Naves PLF	Int J Biol Macromol	10.1016/j.ijbiomac.2017.07.048	2017	*
Pathogenicity	Violacein antimicrobial activity on Staphylococcus epidermidis and synergistic effect on commercially available antibiotics.	Dodou HV, de Morais Batista AH, Sales GWP, de Medeiros SC, Rodrigues ML, Nogueira PCN, Silveira ER, Nogueira NAP	J Appl Microbiol	10.1111/jam.13547	2017	*
Phylogeny	Antituberculotic activity of actinobacteria isolated from the rare habitats.	Hussain A, Rather MA, Shah AM, Bhat ZS, Shah A, Ahmad Z, Parvaiz Hassan Q	Lett Appl Microbiol	10.1111/lam.12773	2017	*
Metabolism	Staphylococcus epidermidis lipoteichoic acid: exocellular release and ltaS gene expression in clinical and commensal isolates.	Garcia-Gomez E, Miranda-Ozuna JFT, Diaz-Cedillo F, Vazquez-Sanchez EA, Rodriguez-Martinez S, Jan-Roblero J, Cancino-Diaz ME, Cancino-Diaz JC	J Med Microbiol	10.1099/jmm.0.000502	2017	*
Phylogeny	Microbiological analysis, antimicrobial activity, and heavy-metals content of Jordanian Ma'in hot-springs water.	Shakhatreh MAK, Jacob JH, Hussein EI, Masadeh MM, Obeidat SM, Juhmani AF, Abd Al-Razaq MA	J Infect Public Health	10.1016/j.jiph.2017.01.010	2017	*
Pathogenicity	Recommendations for Best Disinfectant Practices to Reduce the Spread of Infection via Wrestling Mats.	Young LM, Motz VA, Markey ER, Young SC, Beaschler RE	J Athl Train	10.4085/1062-6050-52.1.02	2017	*
Pathogenicity	Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds.	Moreira CS, Silva AC, Novais JS, Sa Figueiredo AM, Ferreira VF, da Rocha DR, Castro HC	J Appl Microbiol	10.1111/jam.13369	2017	*
Pathogenicity	In vitro assessment of an antibacterial quaternary ammonium-based polymer loaded with chlorhexidine for the coating of polypropylene prosthetic meshes.	Perez-Kohler B, Fernandez-Gutierrez M, Pascual G, Garcia-Moreno F, San Roman J, Bellon JM	Hernia	10.1007/s10029-016-1537-z	2016	*
Cultivation	Cultivation of Staphylococcus epidermidis in the Human Spaceflight Environment Leads to Alterations in the Frequency and Spectrum of Spontaneous Rifampicin-Resistance Mutations in the rpoB Gene.	Fajardo-Cavazos P, Nicholson WL	Front Microbiol	10.3389/fmicb.2016.00999	2016	*
Pathogenicity	Different behavior of Staphylococcus epidermidis in intracellular biosynthesis of silver and cadmium sulfide nanoparticles: more stability and lower toxicity of extracted nanoparticles.	Rezvani Amin Z, Khashyarmanesh Z, Fazly Bazzaz BS	World J Microbiol Biotechnol	10.1007/s11274-016-2110-8	2016	*
Pathogenicity	Antimicrobial Activities of Thai Traditional Remedy "Kheaw-Hom" and Its Plant Ingredients for Skin Infection Treatment in Chickenpox.	Sukkasem K, Panthong S, Itharat A	J Med Assoc Thai		2016	*
Enzymology	Chemical composition and antimicrobial activity of the essential oils of Onychopetalum amazonicum R.E.Fr.	de Lima BR, da Silva FM, Soares ER, de Almeida RA, da Silva Filho FA, Pereira Junior RC, Hernandez Tasco AJ, Salvador MJ, Koolen HH, de Souza AD, Pinheiro ML	Nat Prod Res	10.1080/14786419.2016.1163691	2016	*
Pathogenicity	Inhibition of Bacterial Attachment on Surfaces by Immobilization of Tobramycin-Loaded Liposomes.	Mourtas S, Diamanti G, Foka A, Dracopoulos V, Klepetsanis P, Stamouli V, Spiliopoulou I, Antimisiaris SG	J Biomed Nanotechnol	10.1166/jbn.2015.2160	2015	*
Metabolism	Comparative analysis of Staphylococcus epidermidis strains utilizing quantitative and cell surface shaving proteomics.	Solis N, Cain JA, Cordwell SJ	J Proteomics	10.1016/j.jprot.2015.09.011	2015	*
Pathogenicity	Potency and penetration of telavancin in staphylococcal biofilms.	Kirker KR, Fisher ST, James GA	Int J Antimicrob Agents	10.1016/j.ijantimicag.2015.05.022	2015	*
Metabolism	Amino acid conversions by coagulase-negative staphylococci in a rich medium: Assessment of inter- and intraspecies heterogeneity.	Stavropoulou DA, Borremans W, De Vuyst L, De Smet S, Leroy F	Int J Food Microbiol	10.1016/j.ijfoodmicro.2015.04.048	2015	*
Pathogenicity	Antimicrobial activity and chemical composition of the essential oils of Portuguese Foeniculum vulgare fruits.	Mota AS, Martins MR, Arantes S, Lopes VR, Bettencourt E, Pombal S, Gomes AC, Silva LA	Nat Prod Commun		2015	*
Pathogenicity	Synthesis, characterization and antimicrobial activity of water-soluble silver(i) complexes of metronidazole drug and selected counter-ions.	Kalinowska-Lis U, Felczak A, Checinska L, Zawadzka K, Patyna E, Lisowska K, Ochocki J	Dalton Trans	10.1039/c5dt00403a	2015	*
Metabolism	Possible Correlation Between Bile Salt Hydrolysis and AHL Deamidation: Staphylococcus epidermidis RM1, a Potent Quorum Quencher and Bile Salt Hydrolase Producer.	Mukherji R, Prabhune A	Appl Biochem Biotechnol	10.1007/s12010-015-1563-9	2015	*
Pathogenicity	Evaluation of the antibacterial effects of vancomycin hydrochloride released from agar-gelatin-bioactive glass composites.	Rivadeneira J, Di Virgilio AL, Audisio MC, Boccaccini AR, Gorustovich AA	Biomed Mater	10.1088/1748-6041/10/1/015011	2015	*
Pathogenicity	In-vitro screening of Malaysian honey from different floral sources for antibacterial activity on human pathogenic bacteria.	Ng WJ, Ken KW, Kumar RV, Gunasagaran H, Chandramogan V, Lee YY	Afr J Tradit Complement Altern Med	10.4314/ajtcam.v11i2.14	2014	*
Metabolism	Extracellular biosynthesis of zinc oxide nanoparticles using Rhodococcus pyridinivorans NT2: multifunctional textile finishing, biosafety evaluation and in vitro drug delivery in colon carcinoma.	Kundu D, Hazra C, Chatterjee A, Chaudhari A, Mishra S	J Photochem Photobiol B	10.1016/j.jphotobiol.2014.08.001	2014	*
Enzymology	Antibacterial tetraoxygenated xanthones from the immature fruits of Garcinia cowa.	Auranwiwat C, Trisuwan K, Saiai A, Pyne SG, Ritthiwigrom T	Fitoterapia	10.1016/j.fitote.2014.08.003	2014	*
Genetics	Genomics and Proteomics Provide New Insight into the Commensal and Pathogenic Lifestyles of Bovine- and Human-Associated Staphylococcus epidermidis Strains.	Savijoki K, Iivanainen A, Siljamaki P, Laine PK, Paulin L, Karonen T, Pyorala S, Kankainen M, Nyman TA, Salomaki T, Koskinen P, Holm L, Simojoki H, Taponen S, Sukura A, Kalkkinen N, Auvinen P, Varmanen P	J Proteome Res	10.1021/pr500322d	2014	*
Proteome	Comparative proteome profiling of bovine and human Staphylococcus epidermidis strains for screening specifically expressed virulence and adaptation proteins.	Siljamaki P, Varmanen P, Kankainen M, Pyorala S, Karonen T, Iivanainen A, Auvinen P, Paulin L, Laine PK, Taponen S, Simojoki H, Sukura A, Nyman TA, Savijoki K	Proteomics	10.1002/pmic.201300275	2014	*
Metabolism	Comparative exoprotein profiling of different Staphylococcus epidermidis strains reveals potential link between nonclassical protein export and virulence.	Siljamaki P, Varmanen P, Kankainen M, Sukura A, Savijoki K, Nyman TA	J Proteome Res	10.1021/pr500075j	2014	*
Pathogenicity	Evaluation of antibacterial and cytotoxic effects of nano-sized bioactive glass/collagen composites releasing tetracycline hydrochloride.	Rivadeneira J, Di Virgilio AL, Audisio MC, Boccaccini AR, Gorustovich AA	J Appl Microbiol	10.1111/jam.12476	2014	*
Pathogenicity	Effect of bacterial cell-free supernatants on infectivity of norovirus surrogates.	Shearer AE, Hoover DG, Kniel KE	J Food Prot	10.4315/0362-028X.JFP-13-204	2014	*
Pathogenicity	Synthesis, characterization, crystal structure determination and biological screening of novel N-1 and C5 alkyl substituted scaffolds of pyrimidine.	Pathan NB, Parvez A, Bader A, Shaheen U, Hadda TB	Eur J Med Chem	10.1016/j.ejmech.2013.12.036	2014	*
Metabolism	The use of nucleosides and arginine as alternative energy sources by coagulase-negative staphylococci in view of meat fermentation.	Janssens M, Van der Mijnsbrugge A, Sanchez Mainar M, Balzarini T, De Vuyst L, Leroy F	Food Microbiol	10.1016/j.fm.2013.11.004	2013	*
Pathogenicity	Enhanced pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations.	Hodgson SD, Greco-Stewart V, Jimenez CS, Sifri CD, Brassinga AK, Ramirez-Arcos S	Transfusion	10.1111/trf.12308	2013	*
Enzymology	Bioactivities of Jc-SCRIP, a type 1 ribosome-inactivating protein from Jatropha curcas seed coat.	Nuchsuk C, Wetprasit N, Roytrakul S, Choowongkomon K, T-Thienprasert N, Yokthongwattana C, Arpornsuwan T, Ratanapo S	Chem Biol Drug Des	10.1111/cbdd.12175	2013	*
Pathogenicity	Synthesis and biological evaluation of new 2-azetidinones with sulfonamide structures.	Dragostin OM, Lupascu F, Vasile C, Mares M, Nastasa V, Moraru RF, Pieptu D, Profire L	Molecules	10.3390/molecules18044140	2013	*
Pathogenicity	Evaluation of silicon oil on bacterial growth.	Adams F, Romero IL, Silva CB, Manzano RP	Arq Bras Oftalmol	10.1590/s0004-27492012000200003	2012	*
Genetics	Two novel arginine catabolic mobile elements and staphylococcal chromosome cassette mec composite islands in community-acquired methicillin-resistant Staphylococcus aureus genotypes ST5-MRSA-V and ST5-MRSA-II.	Urushibara N, Kawaguchiya M, Kobayashi N	J Antimicrob Chemother	10.1093/jac/dks157	2012	*
Pathogenicity	Semisynthesis and antimicrobial activity of novel guttiferone-A derivatives.	Dias KS, Januario JP, D' Dego JL, Dias AL, dos Santos MH, Camps I, Coelho LF, Viegas C Jr	Bioorg Med Chem	10.1016/j.bmc.2012.02.023	2012	*
Pathogenicity	Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid.	Schwameis R, Fille M, Manafi M, Zeitlinger M, Sauermann R	Res Microbiol	10.1016/j.resmic.2011.12.004	2011	*
Pathogenicity	Chemical composition and antimicrobial activity of Anthriscus nemorosa root essential oil.	Pavlovic M, Petrovic S, Milenkovic M, Couladis M, Tzakou O, Niketic M	Nat Prod Commun		2011	*
Pathogenicity	Use of antibiotic - impregnated DuraGen(R) to reduce the risk of infection in dura repair: an in vitro study.	Kaplan M, Akgun B, Demirdag K, Akpolat N, Kozan SK, Cagasar O, Yakar H	Cent Eur Neurosurg	10.1055/s-0030-1267246	2011	*
Genetics	Characterization of a novel arginine catabolic mobile element (ACME) and staphylococcal chromosomal cassette mec composite island with significant homology to Staphylococcus epidermidis ACME type II in methicillin-resistant Staphylococcus aureus genotype ST22-MRSA-IV.	Shore AC, Rossney AS, Brennan OM, Kinnevey PM, Humphreys H, Sullivan DJ, Goering RV, Ehricht R, Monecke S, Coleman DC	Antimicrob Agents Chemother	10.1128/AAC.01756-10	2011	*
Pathogenicity	Gemifloxacin mesylate (GFM) stability evaluation applying a validated bioassay method and in vitro cytotoxic study.	Paim CS, Fuhr F, Barth AB, Goncalves CE, Nardi N, Steppe M, Schapoval EE	Talanta	10.1016/j.talanta.2010.11.069	2010	*
Metabolism	Characterization of the histidine decarboxylase gene of Staphylococcus epidermidis TYH1 coded on the staphylococcal cassette chromosome.	Yokoi KJ, Harada Y, Shozen K, Satomi M, Taketo A, Kodaira K	Gene	10.1016/j.gene.2011.01.003	2011	*
Pathogenicity	Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy.	Mendes RE, Deshpande LM, Farrell DJ, Spanu T, Fadda G, Jones RN	J Antimicrob Chemother	10.1093/jac/dkq331	2010	*
Enzymology	Evaluation of the antioxidant and antimicrobial properties of in vitro cultured Drosera intermedia extracts.	Grevenstuk T, Goncalves S, Almeida S, Coelho N, Quintas C, Gaspar MN, Romano A	Nat Prod Commun		2009	*
Pathogenicity	Berberine inhibits Staphylococcus epidermidis adhesion and biofilm formation on the surface of titanium alloy.	Wang X, Qiu S, Yao X, Tang T, Dai K, Zhu Z	J Orthop Res	10.1002/jor.20917	2009	*
Pathogenicity	Caenorhabditis elegans as a host model for community-associated methicillin-resistant Staphylococcus aureus.	Wu K, Conly J, McClure JA, Elsayed S, Louie T, Zhang K	Clin Microbiol Infect	10.1111/j.1469-0691.2009.02765.x	2009	*
Pathogenicity	Antimicrobial activity of Drosophyllum lusitanicum, an endemic Mediterranean insectivorous plant.	Goncalves S, Quintas C, Gaspar MN, Nogueira JM, Romano A	Nat Prod Res	10.1080/14786410801972870	2009	*
Metabolism	Microbiological assay for ceftazidime injection.	De Haro Moreno A, Salgado HR	J AOAC Int		2007	*
Pathogenicity	The effect of aspirin on adherence of slime-producing, coagulase-negative staphylococci to vascular grafts.	Demirag MK, Esen S, Zivalioglu M, Leblebicioglu H, Keceligil HT	Ann Vasc Surg	10.1016/j.avsg.2006.06.006	2007	*
Pathogenicity	Identification of antibacterial constituents from the indigenous Australian medicinal plant Eremophila duttonii F. Muell. (Myoporaceae).	Smith JE, Tucker D, Watson K, Jones GL	J Ethnopharmacol	10.1016/j.jep.2007.03.031	2007	*
Pathogenicity	In vitro antimicrobial activity of different gutta-percha points and calcium hydroxide pastes.	Tanomaru JM, Pappen FG, Tanomaru Filho M, Spolidorio DM, Ito IY	Braz Oral Res	10.1590/s1806-83242007000100006	2007	*
Pathogenicity	Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluation.	Shaikh AR, Giridhar R, Yadav MR	Int J Pharm	10.1016/j.ijpharm.2006.11.037	2006	*
Pathogenicity	Biofilm formation on hydrophilic intraocular lens material.	Shimizu K, Kobayakawa S, Tsuji A, Tochikubo T	Curr Eye Res	10.1080/02713680601038816	2006	*
Phylogeny	Insight in to the phylogeny of polyhydroxyalkanoate biosynthesis: horizontal gene transfer.	Kalia VC, Lal S, Cheema S	Gene	10.1016/j.gene.2006.09.010	2006	*
Metabolism	Comparative proteomic analysis between the invasive and commensal strains of Staphylococcus epidermidis.	Yang XM, Li N, Chen JM, Ou YZ, Jin H, Lu HJ, Zhu YL, Qin ZQ, Qu D, Yang PY	FEMS Microbiol Lett	10.1111/j.1574-6968.2006.00327.x	2006	*
Pathogenicity	Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.	Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJ	Food Chem Toxicol	10.1016/j.fct.2005.08.008	2006	*
Phylogeny	Conserved genes in a path from commensalism to pathogenicity: comparative phylogenetic profiles of Staphylococcus epidermidis RP62A and ATCC12228.	Wei W, Cao Z, Zhu YL, Wang X, Ding G, Xu H, Jia P, Qu D, Danchin A, Li Y	BMC Genomics	10.1186/1471-2164-7-112	2006	*
Pathogenicity	Synthesis and evaluation of antimicrobial and anticonvulsant activities of some new 3-[2- (5-aryl-1,3,4-oxadiazol-2-yl/4-carbethoxymethylthiazol-2-yl) imino-4-thiazolidinon-5-ylidene]-5-substituted/nonsubstituted 1H-indole-2-ones and investigation of their structure-activity relationships.	Altintas H, Ates O, Uyde-Dogan BS, Alp FI, Kaleli D, Ozdemir O, Birteksoz S, Otuk G, Atana D, Uzun M	Arzneimittelforschung		2006	*
Pathogenicity	Long-chain 3-acyl-4-hydroxycoumarins: structure and antibacterial activity.	Cravotto G, Tagliapietra S, Cappello R, Palmisano G, Curini M, Boccalini M	Arch Pharm (Weinheim)	10.1002/ardp.200500127	2006	*
Pathogenicity	Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.	Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJ	Food Chem Toxicol	10.1016/j.fct.2005.08.030	2005	*
Pathogenicity	Influence of human ascitic fluid on the in vitro antibacterial activity of moxifloxacin.	Miglioli PA, Cappellari G, Cavallaro A, Cardaioli C, Sossai P, Fille M, Allerberger F	J Chemother	10.1179/joc.2005.17.4.401	2005	*
Pathogenicity	Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl) ketoxime derivatives.	Koca M, Servi S, Kirilmis C, Ahmedzade M, Kazaz C, Ozbek B, Otuk G	Eur J Med Chem	10.1016/j.ejmech.2005.07.004	2005	*
Pathogenicity	A multiplex PCR method for the detection of all five individual genes of ica locus in Staphylococcus epidermidis. A survey on 400 clinical isolates from prosthesis-associated infections.	Arciola CR, Gamberini S, Campoccia D, Visai L, Speziale P, Baldassarri L, Montanaro L	J Biomed Mater Res A	10.1002/jbm.a.30445	2005	*
Pathogenicity	In vitro antimicrobial activity of Fill Canal, Sealapex, Mineral Trioxide Aggregate, Portland cement and EndoRez.	Sipert CR, Hussne RP, Nishiyama CK, Torres SA	Int Endod J	10.1111/j.1365-2591.2005.00984.x	2005	*
Pathogenicity	Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing.	Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML	Antimicrob Agents Chemother	10.1128/AAC.49.7.2612-2617.2005	2005	*
Genetics	Description of complete DNA sequence of two plasmids from the nukacin ISK-1 producer, Staphylococcus warneri ISK-1.	Aso Y, Koga H, Sashihara T, Nagao J, Kanemasa Y, Nakayama J, Sonomoto K	Plasmid	10.1016/j.plasmid.2004.08.003	2005	*
Enzymology	Traditional medicine in Sakarya province (Turkey) and antimicrobial activities of selected species.	Uzun E, Sariyar G, Adsersen A, Karakoc B, Otuk G, Oktayoglu E, Pirildar S	J Ethnopharmacol	10.1016/j.jep.2004.07.013	2004	*
Enzymology	RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.	Ghiselli R, Giacometti A, Cirioni O, Dell'Acqua G, Mocchegiani F, Orlando F, D'Amato G, Rocchi M, Scalise G, Saba V	Eur J Vasc Endovasc Surg	10.1016/j.ejvs.2004.03.003	2004	*
Pathogenicity	Novel non-mecA-containing staphylococcal chromosomal cassette composite island containing pbp4 and tagF genes in a commensal staphylococcal species: a possible reservoir for antibiotic resistance islands in Staphylococcus aureus.	Mongkolrattanothai K, Boyle S, Murphy TV, Daum RS	Antimicrob Agents Chemother	10.1128/AAC.48.5.1823-1836.2004	2004	*
Pathogenicity	Search for the insertion element IS256 within the ica locus of Staphylococcus epidermidis clinical isolates collected from biomaterial-associated infections.	Arciola CR, Campoccia D, Gamberini S, Rizzi S, Donati ME, Baldassarri L, Montanaro L	Biomaterials	10.1016/j.biomaterials.2003.11.027	2004	*
Pathogenicity	Synthesis of some new 6-methylimidazo[2,1-b]thiazole-5-carbohydrazide derivatives and their antimicrobial activities.	Ur F, Cesur N, Birteksoz S, Otuk G	Arzneimittelforschung	10.1055/s-0031-1296947	2004	*
Genetics	Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228).	Zhang YQ, Ren SX, Li HL, Wang YX, Fu G, Yang J, Qin ZQ, Miao YG, Wang WY, Chen RS, Shen Y, Chen Z, Yuan ZH, Zhao GP, Qu D, Danchin A, Wen YM	Mol Microbiol	10.1046/j.1365-2958.2003.03671.x	2003	*
Pathogenicity	Synthesis and antimicrobial activity of [2-[2-(N, N-disubstituted thiocarbamoyl-sulfanyl)-acylamino] thiazol-4-yl]acetic acid ethyl esters.	Ates O, Gursoy A, Altintas H, Otuk G, Birteksoz S	Arch Pharm (Weinheim)	10.1002/ardp.200390002	2003	*
Pathogenicity	Remarkable substituent effects on antimicrobial activities of 1,3-diorganylimidazolidinium salts.	Cetinkaya E, Denizci A, Ozdemir I, Ozturk HT, Karaboz I, Cetinkaya B	J Chemother	10.1179/joc.2002.14.3.241	2002	*
Enzymology	Comparison of bacterial and tissue cell initial adhesion on hydrophilic/hydrophobic biomaterials.	Karakecili AG, Gumusderelioglu M	J Biomater Sci Polym Ed	10.1163/156856202317414366	2002	*
Pathogenicity	[In vitro antimicrobial activity of glutaraldehyde plus O-phenylphenol association (ratio 2:1)].	D'Ercole S, Catamo G, De Fazio P, Piccolomini R	Minerva Stomatol		2002	*
Pathogenicity	Synthesis and evaluation of antibacterial activity of some 2-[[alpha-(4-substituted benzoyloxy)-alpha-phenylacetyl or methylacetyl]amino]-5-(4-methoxyphenyl)- 1,3,4-oxadiazoles.	Kocabalkanli A, Ates O, Otuk G	Farmaco	10.1016/s0014-827x(01)01158-2	2001	*
Pathogenicity	Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives.	Ulusoy N, Gursoy A, Otuk G	Farmaco	10.1016/s0014-827x(01)01128-4	2001	*
Pathogenicity	Synthesis of some 4-(alkylidene/arylidene)amino-2,4-dihydro-5- (2-thienyl)-3H-1,2,4-triazole-3-thiones tested for antimicrobial activity.	Ulusoy N, Ergenc N, Otuk G, Kiraz M	Boll Chim Farm		2001	*
Pathogenicity	Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis.	Yanyali A, Cetin S, Talu H, Vahaboglu H	Ophthalmologica	10.1159/000050905	2001	*
Pathogenicity	In vitro activity of fosfomycin in combination with various antistaphylococcal substances.	Grif K, Dierich MP, Pfaller K, Miglioli PA, Allerberger F	J Antimicrob Chemother	10.1093/jac/48.2.209	2001	*
Pathogenicity	Activities of bismuth thiols against staphylococci and staphylococcal biofilms.	Domenico P, Baldassarri L, Schoch PE, Kaehler K, Sasatsu M, Cunha BA	Antimicrob Agents Chemother	10.1128/AAC.45.5.1417-1421.2001	2001	*
Pathogenicity	Synthesis of Mannich bases of some 2,5-disubstituted 4-thiazolidinones and evaluation of their antimicrobial activities.	Kocabalkanli A, Ates O, Otuk G	Arch Pharm (Weinheim)	10.1002/1521-4184(200102)334:2<35::aid-ardp35>3.0.co;2-4	2001	*
Pathogenicity	In vitro evaluation of antimicrobial activity of sealers and pastes used in endodontics.	Leonardo MR, da Silva LA, Tanomaru Filho M, Bonifacio KC, Ito IY	J Endod	10.1097/00004770-200007000-00003	2000	*
Pathogenicity	In vitro adhesion of Staphylococcus epidermidis to intraocular lenses.	Garcia-Saenz MC, Arias-Puente A, Fresnadillo-Martinez MJ, Matilla-Rodriguez A	J Cataract Refract Surg	10.1016/s0886-3350(00)00483-1	2000	*
Pathogenicity	Synthesis and antimicrobial activity of new 6-phenylimidazo[2,1-b]thiazole derivatives.	Ulusoy N, Capan G, Otuk G, Kiraz M	Boll Chim Farm		2000	*
Pathogenicity	Synthesis and antimicrobial activity of 4-carbethoxymethyl-2-[(alpha-haloacyl)amino] thiazoles and 5-nonsubstituted/substituted 2-[(4-carbethoxymethylthiazol-2-yl)imino]-4-thiazolidinones.	Ates O, Altintas H, Otuk G	Arzneimittelforschung	10.1055/s-0031-1300251	2000	*
Pathogenicity	Bactericidal activity of vancomycin in cerebrospinal fluid.	Nagl M, Neher C, Hager J, Pfausler B, Schmutzhard E, Allerberger F	Antimicrob Agents Chemother	10.1128/AAC.43.8.1932	1999	*
Cultivation	Comparison of monolayer and bilayer plates used in antibiotic assay.	Reamer RH, Dey BP, White CA, Mageau RP	J AOAC Int		1998	*
Pathogenicity	Antimicrobial activity of neomycin C against Staphylococcus epidermidis.	Robertson JH, Baas R, Yeager RL, Tsuji K	Appl Microbiol	10.1128/am.22.6.1164-1165.1971	1971	*
Pathogenicity	Comparative effect of seven prophylactic locks to prevent biofilm biomass and viability in intravenous catheters.	Austin PD, Stapleton P, Elia M	J Antimicrob Chemother	10.1093/jac/dkac181	2022	*
	Synthesis, Biological Activity and Molecular Docking Studies of Novel Nicotinic Acid Derivatives.	Paruch K, Biernasiuk A, Khylyuk D, Paduch R, Wujec M, Popiolek L	Int J Mol Sci	10.3390/ijms23052823	2022	*
	The Synergistic Effect of Triterpenoids and Flavonoids-New Approaches for Treating Bacterial Infections?	Wronska N, Szlaur M, Zawadzka K, Lisowska K	Molecules	10.3390/molecules27030847	2022	*
	The effects of TGF-beta1 on staphylococcus epidermidis biofilm formation in a tree shrew biomaterial-centered infection model.	Lei Y, Xu Y, Jing P, Xiang B, Che K, Shen J, Ning M, Chen Y, Huang Y	Ann Transl Med	10.21037/atm-20-4526	2021	*
	Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation.	Pica M, Messere N, Felicetti T, Sabatini S, Pietrella D, Nocchetti M	Materials (Basel)	10.3390/ma14030670	2021	*
	Evaluation of the stability and antibacterial activity of crude extracts of hydro-endophytic fungi.	Techaoei S, Jarmkom K, Dumrongphuttidecha T, Khobjai W	J Adv Pharm Technol Res	10.4103/japtr.JAPTR_114_20	2021	*
	The Genome of Staphylococcus epidermidis O47.	Raue S, Fan SH, Rosenstein R, Zabel S, Luqman A, Nieselt K, Gotz F	Front Microbiol	10.3389/fmicb.2020.02061	2020	*
	Dependence of the Staphylococcal Volatilome Composition on Microbial Nutrition.	Jenkins CL, Bean HD	Metabolites	10.3390/metabo10090347	2020	*
	Essential Oils of Aromatic Plants with Antibacterial, Anti-Biofilm and Anti-Quorum Sensing Activities against Pathogenic Bacteria.	Caceres M, Hidalgo W, Stashenko E, Torres R, Ortiz C	Antibiotics (Basel)	10.3390/antibiotics9040147	2020	*
	Zinc(II) Complexes with Amino Acids for Potential Use in Dermatology: Synthesis, Crystal Structures, and Antibacterial Activity.	Abendrot M, Checinska L, Kusz J, Lisowska K, Zawadzka K, Felczak A, Kalinowska-Lis U	Molecules	10.3390/molecules25040951	2020	*
	Miniaturized turbidimetric assay: A green option for the analysis of besifloxacin in ophthalmic suspension.	Totoli EG, Salgado HRN	Talanta	10.1016/j.talanta.2019.120532	2019	*
	[The inhibition of accessory gene regulator C specific binding peptides on biofilm formation of Staphylococcus epidermidis on the surface of polyvinyl chloride in vitro].	Yang J, Qiu L, Huang Y, Chen Y, Rao S, Ruan W, Zhao G, Ye L	Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi	10.7507/1002-1892.201806110	2019	*
	Bioactive Glass Granules Inhibit Mature Bacterial Biofilms on the Surfaces of Cochlear Implants.	Hoing B, Kirchhoff L, Arnolds J, Hussain T, Buer J, Lang S, Arweiler-Harbeck D, Steinmann J	Otol Neurotol	10.1097/MAO.0000000000002021	2018	*
	Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin.	Masadeh MM, Alzoubi KH, Al-Azzam SI, Al-Buhairan AM	Clin Pharmacol	10.2147/CPAA.S148448	2017	*
	Synthesis of Some New Tetrahydropyrimidine Derivatives as Possible Antibacterial Agents.	Foroughifar N, Karimi Beromi S, Pasdar H, Shahi M	Iran J Pharm Res		2017	*
	Chemical constituents of Helichrysum italicum (Roth) G. Don essential oil and their antimicrobial activity against Gram-positive and Gram-negative bacteria, filamentous fungi and Candida albicans.	Djihane B, Wafa N, Elkhamssa S, Pedro HJ, Maria AE, Mohamed Mihoub Z	Saudi Pharm J	10.1016/j.jsps.2016.11.001	2016	*
	Distinct growth and extractive methods of Acmellaoleracea (L.) R.K. Jansen rising different concentrations of spilanthol: An important bioactive compound in human dietary.	Franca JV, Queiroz MSR, do Amaral BP, Simas NK, da Silva NCB, Leal ICR	Food Res Int	10.1016/j.foodres.2016.09.018	2016	*
	[Estradiol stimulates the growth and biofilm formation of clinical Staphylococcus epidermidis].	Wang X, Zhou YC, Huang YC, Zou TN, Lu ZY, Chen Y, Liu X, Duan WS	Zhonghua Yi Xue Za Zhi	10.3760/cma.j.issn.0376-2491.2016.38.010	2016	*
	[Effect of estradiol on biofilm formation of staphylococcus epidermidis after breast implant surgery].	Wang X, Huang Y, Zhou Y, Liu D, Lu Z, Ye L, Chen Y, Yang J, Chen P, Wang Z	Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi	10.7507/1002-1892.20160178	2016	*
	Enhanced osteogenic and selective antibacterial activities on micro-/nano-structured carbon fiber reinforced polyetheretherketone.	Lu T, Li J, Qian S, Cao H, Ning C, Liu X	J Mater Chem B	10.1039/c6tb00268d	2016	*
	Rapid turbidimetric assay for quantification of fusidic acid in a dermatological cream.	Curbete MM, Salgado HR	Talanta	10.1016/j.talanta.2016.01.069	2016	*
	[EFFECT OF INFECTION ON CAPSULE FORMATION AFTER BREAST IMPLANTS].	Tang Q, Zhou S, Huang Y	Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi		2015	*
	Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents.	Masadeh MM, Alzoubi KH, Al-Azzam SI, Khabour OF, Al-Buhairan AM	Pathogens	10.3390/pathogens5010028	2016	*
	Oscillational motion properties of bacteria and polystyrene particles on a positively polarized substrate surface.	Shim S, Kang H, Ahn KH, Yoon J	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2015.06.058	2015	*
	Quantitatively predicting bacterial adhesion using surface free energy determined with a spectrophotometric method.	Zhang X, Zhang Q, Yan T, Jiang Z, Zhang X, Zuo YY	Environ Sci Technol	10.1021/es5050425	2015	*
	Analyzing the antibacterial effects of food ingredients: model experiments with allicin and garlic extracts on biofilm formation and viability of Staphylococcus epidermidis.	Wu X, Santos RR, Fink-Gremmels J	Food Sci Nutr	10.1002/fsn3.199	2015	*
	Staphylococcus epidermidis Affinity for Fibrinogen-Coated Surfaces Correlates with the Abundance of the SdrG Adhesin on the Cell Surface.	Vanzieleghem T, Herman-Bausier P, Dufrene YF, Mahillon J	Langmuir	10.1021/acs.langmuir.5b00360	2015	*
	Biofilm Formation by Staphylococcus epidermidis on Foldable and Rigid Intraocular Lenses.	Fazly Bazzaz BS, Jalalzadeh M, Sanati M, Zarei-Ghanavati S, Khameneh B	Jundishapur J Microbiol	10.5812/jjm.10020	2014	*
	Quantitative evaluation of besifloxacin ophthalmic suspension by HPLC, application to bioassay method and cytotoxicity studies.	Costa MC, Barden AT, Andrade JM, Oppe TP, Schapoval EE	Talanta	10.1016/j.talanta.2013.10.051	2013	*
	A novel and rapid microbiological assay for ciprofloxacin hydrochloride.	Cazedey ECL, Salgado HRN	J Pharm Anal	10.1016/j.jpha.2013.03.007	2013	*
	Effect of Ottoman Viper (Montivipera xanthina (Gray, 1849)) Venom on Various Cancer Cells and on Microorganisms.	Yalcin HT, Ozen MO, Gocmen B, Nalbantsoy A	Cytotechnology	10.1007/s10616-013-9540-z	2013	*
	An in vitro and in vivo study on the intensity of adhesion and colonization by Staphylococcus epidermidis and Pseudomonas aeruginosa on originally synthesized biomaterials with different chemical composition and modified surfaces and their effect on expression of TNF-alpha, beta-defensin 2 and IL-10 in tissues.	Reinis A, Pilmane M, Stunda A, Vetra J, Kroica J, Rostoka D, Salms G, Vostroilovs A, Dons A, Berzina-Cimdina L	Medicina (Kaunas)	1110-06e	2011	*
	Composition and antimicrobial activity of Seseli globiferum essential oil.	Janackovic P, Sokovic M, Vujisic L, Vajs V, Vuckovic I, Krivosej Z, Marin PD	Nat Prod Commun		2011	*
	Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.	Wu XW, Wu ZP, Wang LX, Zhang HB, Chen JW, Zhang W, Gu LQ, Huang ZS, An LK	Eur J Med Chem	10.1016/j.ejmech.2011.07.042	2011	*
	Synthesis, Characterization and Antimicrobial Activity of d Metal Complexes of some 2-Substituted-1H-Benzimidazoles.	Ulkuseven B, Tavman A, Otuk G	Met Based Drugs	10.1155/MBD.1999.163	1999	*
	Biofilm formation by Staphylococcus epidermidis on intraocular lens material.	Okajima Y, Kobayakawa S, Tsuji A, Tochikubo T	Invest Ophthalmol Vis Sci	10.1167/iovs.05-1172	2006	*
	Gunshot-related transport of micro-organisms from the skin of the entrance region into the bullet path.	Grosse Perdekamp M, Kneubuehl BP, Serr A, Vennemann B, Pollak S	Int J Legal Med	10.1007/s00414-005-0073-7	2006	*
	Adherence of two strains of Staphylococcus epidermidis to contact lenses.	Garcia-Saenz MC, Arias-Puente A, Fresnadillo-Martinez MJ, Paredes-Garcia B	Cornea	10.1097/00003226-200207000-00014	2002	*
	Cryopreservation of bacterial vegetative cells used in antibiotic assay.	Reamer R, Dey BP, Thaker N	J AOAC Int		1995	*
	A Practical Evaluation of the Delvotest P Multi Plate Test in Screening Raw Milk for Antibiotics.	Larocque L, Neville GA	J Food Prot	10.4315/0362-028X-49.11.868	1986	*
	Increase in sensitivity for the assay of neomycin in milk.	Siddique IH, Loken KI, Hoyt HH	Appl Microbiol	10.1128/am.13.5.635-637.1965	1965	*
	Component Composition and Biological Activity of Various Extracts of Onosma gmelinii (Boraginaceae).	Shilov SV, Ustenova GO, Kiyekbayeva LN, Korotetskiy IS, Kudashkina NV, Zubenko NV, Parenova RA, Jumagaziyeva AB, Iskakbayeva ZA, Kenesheva ST	Int J Biomater	10.1155/2022/4427804	2022	*
	Design, Synthesis and Preliminary Evaluation of the Cytotoxicity and Antibacterial Activity of Novel Triphenylphosphonium Derivatives of Betulin.	Grymel M, Lalik A, Kazek-Kesik A, Szewczyk M, Grabiec P, Erfurt K	Molecules	10.3390/molecules27165156	2022	*
	Chemical Composition and the Anticancer, Antimicrobial, and Antioxidant Properties of Acacia Honey from the Hail Region: The in vitro and in silico Investigation.	Hamadou WS, Bouali N, Badraoui R, Hadj Lajimi R, Hamdi A, Alreshidi M, Patel M, Adnan M, Siddiqui AJ, Noumi E, Rao Pasupuleti V, Snoussi M	Evid Based Complement Alternat Med	10.1155/2022/1518511	2022	*

References

#659	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 1798

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#41765 ; Curators of the CIP;
#47537 Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 21989

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68375

Automatically annotated from API ID32STA .

#68378

Automatically annotated from API STA .

#68379

Automatically annotated from API Coryne .

#68382

Automatically annotated from API zym .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#83653

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID13849.1 )

#119105 Collection of Institut Pasteur ; Curators of the CIP; CIP 68.21

#124043

Dr. Isabel Schober, Dr. Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy .

* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Staphylococcus epidermidis in external resources:
SILVA
BRENDA
PANGAEA
GBIF

Staphylococcus epidermidis ATCC 12228 ATCC 12228

Staphylococcus epidermidis ATCC 12228 ATCC 12228

Change proposal

Change proposal